GLORIA

GEOMAR Library Ocean Research Information Access

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Online-Ressource
    Online-Ressource
    SAGE Publications ; 2018
    In:  HIP International Vol. 28, No. 6 ( 2018-11), p. 584-590
    In: HIP International, SAGE Publications, Vol. 28, No. 6 ( 2018-11), p. 584-590
    Kurzfassung: Cadaveric and clinical studies suggest surgical release of the short external rotators is sometimes necessary to improve exposure during total hip arthroplasty (THA) using an anterior approach. The purpose of this study was to determine the impact of those surgical releases on gait following THA. Methods: 15 patients undergoing THA using an anterior approach, anterior approach with surgical releases, or posterior approach underwent 3-D gait analysis preoperatively, and at 6 and 12 weeks postoperatively. At each time point, temporal parameters, kinematics, and kinetics were compared. The anterior approach was compared to the anterior approach cohort with surgical releases, and the surgical release cohort was compared to a posterior approach cohort. The mean change score between preoperative and 6 weeks, and 6-week to 12-week analyses were analysed. Results: There were no demographic differences between the groups. There were no significant differences between the groups for the temporal parameters and kinematic analyses at either time point comparison. The surgical release cohort had a lower hip internal rotation moment compared to the anterior approach cohort for the 6- to 12-week comparison ( p = 0.05), and compared to the posterior approach cohort for the preoperative to 6-week ( p = 0.03) and 6- to 12-week comparison ( p = 0.02). Conclusion: Releasing the short external rotators during an anterior approach did not cause significant temporal and kinematic changes after THA. However, small changes in hip internal rotation moments can be expected. These findings should be correlated with patient-reported outcome measures to determine if these gait anomalies predict poor outcome following THA.
    Materialart: Online-Ressource
    ISSN: 1120-7000 , 1724-6067
    Sprache: Englisch
    Verlag: SAGE Publications
    Publikationsdatum: 2018
    ZDB Id: 1475775-8
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Online-Ressource
    Online-Ressource
    Ovid Technologies (Wolters Kluwer Health) ; 2020
    In:  Journal of Bone and Joint Surgery Vol. 102, No. 5 ( 2020-3-4), p. 381-387
    In: Journal of Bone and Joint Surgery, Ovid Technologies (Wolters Kluwer Health), Vol. 102, No. 5 ( 2020-3-4), p. 381-387
    Kurzfassung: The efficacy and safety of tranexamic acid (TXA) in primary total knee arthroplasty (TKA) have been well established. However, there have been limited data for revision TKAs. The primary aim was to assess the impact of intravenous TXA on transfusion rates and symptomatic venous thromboembolic events (VTEs) in a large revision TKA cohort with or without intravenous TXA utilization. Methods: A retrospective review of revision TKAs performed from 2005 to 2014 was performed, identifying 2,951 procedures (2,219 patients), in which TXA was utilized in 1,144 procedures (39%). The mean age was 65 years with 52% female patients in the TXA revision group and 67 years with 52% female patients in the non-TXA revision group. Transfusion rates and symptomatic VTEs were the primary outcomes assessed. Comparisons were performed between cohorts, utilizing a unique propensity model to mitigate bias, on the basis of TXA use and subsequently for aseptic or septic revision etiology. Results: Significant reductions in transfusion rates with use of TXA were identified in revision TKAs overall (13% compared with 39%; p 〈 0.001 [adjusted relative risk, 1.7]), including revisions for both aseptic etiology (6% with TXA compared with 28% without TXA; p 〈 0.001) and septic etiology (31% with TXA compared with 54% without TXA; p 〈 0.001). The risk of a postoperative symptomatic VTE was not significantly different (adjusted p = 0.63) with use of TXA at 11 events (1.0%) compared with 24 events (1.3%) in the non-TXA group). Conclusions: Intravenous TXA significantly reduced transfusion rates in revision TKAs by approximately twofold, including cohorts revised for aseptic and septic etiologies. There was a very low rate of VTEs (1.2%) with no significant difference in the number of VTEs between groups after adjusting risk utilizing propensity modeling. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
    Materialart: Online-Ressource
    ISSN: 0021-9355 , 1535-1386
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 2020
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    Online-Ressource
    Online-Ressource
    Elsevier BV ; 2017
    In:  The Journal of Arthroplasty Vol. 32, No. 11 ( 2017-11), p. 3510-3518
    In: The Journal of Arthroplasty, Elsevier BV, Vol. 32, No. 11 ( 2017-11), p. 3510-3518
    Materialart: Online-Ressource
    ISSN: 0883-5403
    Sprache: Englisch
    Verlag: Elsevier BV
    Publikationsdatum: 2017
    ZDB Id: 2041553-9
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 4
    In: Canadian Journal of Surgery, CMA Impact Inc., Vol. 59, No. 1 ( 2016-02), p. 48-53
    Materialart: Online-Ressource
    ISSN: 0008-428X , 1488-2310
    Sprache: Englisch
    Verlag: CMA Impact Inc.
    Publikationsdatum: 2016
    ZDB Id: 2026595-5
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 5
    Online-Ressource
    Online-Ressource
    Elsevier BV ; 2022
    In:  Arthroplasty Today Vol. 14 ( 2022-04), p. 96-99
    In: Arthroplasty Today, Elsevier BV, Vol. 14 ( 2022-04), p. 96-99
    Materialart: Online-Ressource
    ISSN: 2352-3441
    Sprache: Englisch
    Verlag: Elsevier BV
    Publikationsdatum: 2022
    ZDB Id: 2858808-3
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 6
    Online-Ressource
    Online-Ressource
    Ovid Technologies (Wolters Kluwer Health) ; 2019
    In:  Clinical Orthopaedics & Related Research Vol. 477, No. 1 ( 2019-01), p. 70-77
    In: Clinical Orthopaedics & Related Research, Ovid Technologies (Wolters Kluwer Health), Vol. 477, No. 1 ( 2019-01), p. 70-77
    Kurzfassung: Unicompartmental knee arthroplasty restores function and improves pain in appropriately selected patients. Scant evidence exists regarding the treatment of periprosthetic joint infection (PJI) after unicompartmental knee arthroplasty (UKA). Questions/purposes (1) What was the overall survivorship free from reinfection? (2) What is the survivorship free of all-cause revision? (3) What are the Knee Society scores (KSS) and complications after surgical treatment of UKA PJI? Methods This retrospective study with data drawn from a longitudinally maintained institutional registry identified 15 UKA PJIs between 1992 and 2014. The median age at PJI diagnosis was 58 years (range, 41-82 years), nine of 15 were men, and the median body mass index was 29 kg/m 2 (range, 23-36 kg/m 2 ). Ten patients (10 of 15) satisfied major Musculoskeletal Infection Society diagnostic criteria. There were five patients (five of 15) with early postoperative infections, five (five of 15) with acute hematogenous infections, and five (five of 15) with chronic PJIs. Two-stage exchange was performed in four patients with PJIs (four of 15), and débridement, antibiotics, and implant retention (DAIR) was performed in 11 patients (11 of 15) with PJIs. We performed Kaplan-Meier survivorship analysis for reinfection and revision procedures. Thirteen patients had a minimum of 2 years’ followup and were included in the clinical analysis. Median followup was 4 years (range, 2-6 years). We calculated KSS. Results Infection-free survivorship was 71% at 5 years (95% confidence interval [CI], 46%–96%). Treatment success was higher for patients undergoing two-stage exchange (100% at 5 years; 95% CI, 100%–100%) versus DAIR (61% at 5 years; 95% CI, 31%–92%). Four of 11 patients undergoing DAIR had developed a reinfection at final followup. Survivorship free of any revision was 49% at 5 years (95% CI, 19%–79%). One patient from the two-stage exchange cohort underwent femoral component revision for aseptic loosening 5 years after PJI treatment, and two patients from the DAIR group were converted to TKA for disease progression at a mean of 4 years. In patients with a m inimum of 2 years’ followup, median KSS improved from 73 (range, 50-93) before index UKA to 94 (range, 55-100; p = 0.016). Conclusions Treatment of UKA PJI with DAIR was associated with a lower infection-free survivorship at 5 years compared with two-stage exchange with conversion to TKA. Among those patients who were infection-free, a number needed reoperations for disease progression (in the DAIR group) or component loosening (in both groups). UKA PJI results in substantial morbidity, and patients with these infections should be followed closely for aseptic causes of failure in addition to infection recurrence. Level of Evidence Level IV, therapeutic study.
    Materialart: Online-Ressource
    ISSN: 0009-921X
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 2019
    ZDB Id: 2018318-5
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 7
    Online-Ressource
    Online-Ressource
    Elsevier BV ; 2016
    In:  The Journal of Arthroplasty Vol. 31, No. 7 ( 2016-07), p. 1427-1430
    In: The Journal of Arthroplasty, Elsevier BV, Vol. 31, No. 7 ( 2016-07), p. 1427-1430
    Materialart: Online-Ressource
    ISSN: 0883-5403
    Sprache: Englisch
    Verlag: Elsevier BV
    Publikationsdatum: 2016
    ZDB Id: 2041553-9
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 8
    Online-Ressource
    Online-Ressource
    Ovid Technologies (Wolters Kluwer Health) ; 2019
    In:  Journal of Bone and Joint Surgery Vol. 101, No. 3 ( 2019-2-6), p. 239-249
    In: Journal of Bone and Joint Surgery, Ovid Technologies (Wolters Kluwer Health), Vol. 101, No. 3 ( 2019-2-6), p. 239-249
    Kurzfassung: For patients undergoing 2-stage exchange for the treatment of periprosthetic joint infection (PJI) following total knee arthroplasty, the long-term risk of reinfection and mechanical failure and long-term clinical outcomes are not well known. The purpose of our study was to determine the long-term clinical results of 2-stage exchange for PJI following total knee arthroplasty. Methods: We identified 245 knees that had undergone total knee arthroplasty and were subsequently treated with 2-stage exchange due to infection during the period of 1991 to 2006; the cohort had no prior treatment for PJI. Major, or 4 of 6 minor, Musculoskeletal Infection Society (MSIS) diagnostic criteria were fulfilled by 179 (73%) of the knees. The cumulative incidence of reinfection and of aseptic revision, accounting for the competing risk of death, were calculated. Risk factors for reinfection were evaluated using Cox proportional hazards regression. Knee Society Score (KSS) values were calculated. The mean age at spacer insertion was 68 years; 50% of the patients were female. The mean follow-up was 14 years (range, 2 to 25 years) following reimplantation. Results: The cumulative incidence of reinfection was 4% at 1 year, 14% at 5 years, 16% at 10 years, and 17% at 15 years. Factors that were predictive of reinfection included a body mass index of ≥30 kg/m 2 (hazard ratio [HR], 3.1; p 〈 0.01), previous revision surgery (HR, 2.8; p 〈 0.01), and a McPherson host grade of C (HR, 2.5; p = 0.04). The cumulative incidence of aseptic revision for loosening was 2% at 5 years, 5% at 10 years, and 7% at 15 years. Femoral (HR, 5.0; p = 0.04) and tibial (HR, 6.7; p 〈 0.01) bone-grafting at reimplantation were predictive of aseptic failure. The most common complications were wound-healing issues, requiring reoperation in 12 (5%) of the knees. The rate of death at 2 years following reimplantation was 11%. The mean KSS improved from 45 at PJI diagnosis to 76 at 10 years following reimplantation (p 〈 0.01). Conclusions: Long-term reinfection rates following 2-stage exchange for PJI after total knee arthroplasty were similar to those of shorter-term reports and were maintained out to 15 years. Mechanical failure rates were low if bone loss was addressed at the time of reimplantation. Improvements in clinical outcomes were maintained at long-term follow-up. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
    Materialart: Online-Ressource
    ISSN: 0021-9355 , 1535-1386
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 2019
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 9
    Online-Ressource
    Online-Ressource
    Ovid Technologies (Wolters Kluwer Health) ; 2019
    In:  Journal of Bone and Joint Surgery Vol. 101, No. 1 ( 2019-1-2), p. 74-84
    In: Journal of Bone and Joint Surgery, Ovid Technologies (Wolters Kluwer Health), Vol. 101, No. 1 ( 2019-1-2), p. 74-84
    Kurzfassung: Limited data exist that show the long-term risks of reinfection and mechanical failure with a contemporary 2-stage exchange protocol for periprosthetic joint infection following total hip arthroplasty. The purpose of this study was to determine the long-term reinfection and mechanical failure rates of 2-stage exchange for periprosthetic joint infection after total hip arthroplasty. Methods: We identified 164 hips (162 patients) with infection after total hip arthroplasty between 1991 and 2006 treated with a 2-stage exchange protocol with no prior treatment for periprosthetic joint infection. With regard to Musculoskeletal Infection Society diagnostic criteria, at least 1 major criterion or 4 of 6 minor criteria were fulfilled in 129 hips (79%). The cumulative incidence with a competing risk of death was calculated for reinfection, aseptic revisions, and all-cause revisions. The risk factors for reinfection were evaluated using Cox proportional hazards regression. Harris hip scores were calculated. The mean age at the time of spacer insertion was 68 years, and 35% of the patients were female. Excluding the patients with 〈 2 years of follow-up, the mean follow-up was 12 years (range, 2 to 21 years). Results: The cumulative incidence of recurrence of infection was 10% at 1 year, 14% at 5 years, and 15% at 10 and 15 years. Seventeen patients (11%) used chronic antibiotic suppression ( 〉 6 months), with 7 (41%) of these having recurrent infection at the time of the latest follow-up. Use of chronic antibiotic suppression was the only predictive factor for reinfection (hazard ratio, 4.5 [95% confidence interval (CI), 1.9 to 10.9]; p = 0.001). The cumulative incidence of aseptic femoral and acetabular revisions was 2.6% at 5 years and 3.3% at 10 and 15 years. The cumulative incidence of all-cause revisions was 15% at 5 years and 16% at 10 and 15 years. Dislocation was the most common complication, with 28 dislocations occurring in 20 patients (12%). The mean Harris hip score improved from 52 points prior to spacer insertion to 70 points at 15 years after reimplantation (p 〈 0.01). Conclusions: The rate of recurrence of infection of 15% for up to 15 years after total hip arthroplasty was similar to previous shorter-term reports of 2-stage exchange for periprosthetic joint infection. Surgeons should anticipate mitigating instability after reimplantation. Implant survivorship free of aseptic loosening and clinical outcomes were preserved for the long term. The role of chronic antibiotic suppression in the long-term treatment of periprosthetic joint infection requires further investigation. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
    Materialart: Online-Ressource
    ISSN: 0021-9355 , 1535-1386
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 2019
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 10
    Online-Ressource
    Online-Ressource
    Elsevier BV ; 2016
    In:  The Journal of Arthroplasty Vol. 31, No. 1 ( 2016-01), p. 53-58
    In: The Journal of Arthroplasty, Elsevier BV, Vol. 31, No. 1 ( 2016-01), p. 53-58
    Materialart: Online-Ressource
    ISSN: 0883-5403
    Sprache: Englisch
    Verlag: Elsevier BV
    Publikationsdatum: 2016
    ZDB Id: 2041553-9
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...